Skip to main content
Top
Published in: Journal of Neural Transmission 6/2013

01-06-2013 | Neurology and Preclinical Neurological Studies - Original Article

Quantum-chemical approach to determining the high potency of clorgyline as an irreversible acetylenic monoamine oxidase inhibitor

Authors: Matic Pavlin, Janez Mavri, Matej Repič, Robert Vianello

Published in: Journal of Neural Transmission | Issue 6/2013

Login to get access

Abstract

Density functional theory calculations were employed to investigate the nature of chemical bond formation between the flavin co-factor of the enzyme monoamine oxidase (MAO) and its irreversible acetylenic inhibitor clorgyline in its terminally deprotonated anionic form. Since MAOs regulate the level of neurotransmitters in living cells, this reaction is pharmacologically relevant for treating depression and other mood disorders. The results revealed that this pathway is associated with the activation free energy of ΔG act #  = 17.4 kcal mol−1, which, together with our previous results, suggests that clorgyline is intrinsically a more effective MAO inhibitor than antiparkinsonian drugs rasagiline and selegiline considering the preferred MAO isoforms in each case, thus displaying a trend in agreement with experimental data. The reaction is facilitated by the pronounced electrophilic character of the flavin moiety, due to its ability to efficiently accommodate excess negative charge from the approaching anionic inhibitor through resonance effect. The investigated mechanism was additionally validated by the inspection of the geometry of the flavin moiety in the formed adduct, which exhibit distortion from planarity consistent with experimental observations. These results offer valuable insight for mechanistic studies on other flavoenzymes and for the design of new antidepressants and antiparkinsonian drugs.
Literature
go back to reference Akyuz MA, Erdem SS, Edmondson DE (2007) The aromatic cage in the active site of monoamine oxidase B: effect on the structural and electronic properties of bound benzylamine and p-nitrobenzylamine. J Neural Transm 114:693–698 Akyuz MA, Erdem SS, Edmondson DE (2007) The aromatic cage in the active site of monoamine oxidase B: effect on the structural and electronic properties of bound benzylamine and p-nitrobenzylamine. J Neural Transm 114:693–698
go back to reference Barone V, Cossi M (1998) Quantum calculation of molecular energies and energy gradients in solution by a conductor solvent model. J Phys Chem A 102:1995–2001CrossRef Barone V, Cossi M (1998) Quantum calculation of molecular energies and energy gradients in solution by a conductor solvent model. J Phys Chem A 102:1995–2001CrossRef
go back to reference Binda C, Newton-Vinson P, Hubálek F, Edmondson DE, Mattevi A (2002) Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders. Nat Struct Biol 9:22–26PubMedCrossRef Binda C, Newton-Vinson P, Hubálek F, Edmondson DE, Mattevi A (2002) Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders. Nat Struct Biol 9:22–26PubMedCrossRef
go back to reference Binda C, Li M, Hubálek F, Restelli N, Edmondson DE, Mattevi A (2003) Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures. Proc Natl Acad Sci USA 100:9750–9755 Binda C, Li M, Hubálek F, Restelli N, Edmondson DE, Mattevi A (2003) Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures. Proc Natl Acad Sci USA 100:9750–9755
go back to reference Binda C, Hubálek F, Li M, Herzig Y, Sterling J, Edmondson DE, Matevi A (2005) Binding of rasagiline-related inhibitors to human monoamine oxidases: a kinetic and crystallographic analysis. J Med Chem 48:8148–8154PubMedCrossRef Binda C, Hubálek F, Li M, Herzig Y, Sterling J, Edmondson DE, Matevi A (2005) Binding of rasagiline-related inhibitors to human monoamine oxidases: a kinetic and crystallographic analysis. J Med Chem 48:8148–8154PubMedCrossRef
go back to reference Boese AD, Martin JML (2004) Development of density functionals for thermochemical kinetics. J Chem Phys 121:3405–3416PubMedCrossRef Boese AD, Martin JML (2004) Development of density functionals for thermochemical kinetics. J Chem Phys 121:3405–3416PubMedCrossRef
go back to reference Bolea I, Juárez-Jiménez J, de los Ríos C, Chioua M, Pouplana R, Javier Luque F, Unzeta M, Marco-Contelles J, Samadi A (2011) Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease. J Med Chem 54:8251–8270 Bolea I, Juárez-Jiménez J, de los Ríos C, Chioua M, Pouplana R, Javier Luque F, Unzeta M, Marco-Contelles J, Samadi A (2011) Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease. J Med Chem 54:8251–8270
go back to reference Bonivento D, Milczek EM, McDonald GR, Binda C, Holt A, Edmondson DE, Mattevi A (2010) Potentiation of ligand binding through cooperative effects in monoamine oxidase B. J Biol Chem 285:36849–36856PubMedCrossRef Bonivento D, Milczek EM, McDonald GR, Binda C, Holt A, Edmondson DE, Mattevi A (2010) Potentiation of ligand binding through cooperative effects in monoamine oxidase B. J Biol Chem 285:36849–36856PubMedCrossRef
go back to reference Borštnar R, Repič M, Kržan M, Mavri J, Vianello R (2011) Irreversible inhibition of monoamine oxidase B by the antiparkinsonian medicines rasagiline and selegiline: a computational study. Eur J Org Chem 6419–6433 Borštnar R, Repič M, Kržan M, Mavri J, Vianello R (2011) Irreversible inhibition of monoamine oxidase B by the antiparkinsonian medicines rasagiline and selegiline: a computational study. Eur J Org Chem 6419–6433
go back to reference Borštnar R, Repič M, Kamerlin SCL, Vianello R, Mavri J (2012) Computational study of the pKa values of potential catalytic residues in the active site of monoamine oxidase B. J Chem Theory Comput 8:3864–3870CrossRef Borštnar R, Repič M, Kamerlin SCL, Vianello R, Mavri J (2012) Computational study of the pKa values of potential catalytic residues in the active site of monoamine oxidase B. J Chem Theory Comput 8:3864–3870CrossRef
go back to reference Collins GGS, Sandler M, Williams ED, Youdim MBH (1970) Multiple forms of human brain mitochondrial monoamine oxidase. Nature 225:817–820PubMedCrossRef Collins GGS, Sandler M, Williams ED, Youdim MBH (1970) Multiple forms of human brain mitochondrial monoamine oxidase. Nature 225:817–820PubMedCrossRef
go back to reference Cossi M, Rega N, Scalmani G, Barone V (2003) Energies, structures, and electronic properties of molecules in solution with the C-PCM solvation model. J Comput Chem 24:669–681PubMedCrossRef Cossi M, Rega N, Scalmani G, Barone V (2003) Energies, structures, and electronic properties of molecules in solution with the C-PCM solvation model. J Comput Chem 24:669–681PubMedCrossRef
go back to reference De Colibus L, Li M, Binda C, Lustig A, Edmondson DE, Mattevi A (2005) Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B. Proc Natl Acad Sci USA 102:12684–12689PubMedCrossRef De Colibus L, Li M, Binda C, Lustig A, Edmondson DE, Mattevi A (2005) Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B. Proc Natl Acad Sci USA 102:12684–12689PubMedCrossRef
go back to reference Di Monte DA, DeLanney LE, Irwin I, Royland JE, Chan P, Jakowec MW, Langston JW (1996) Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys. Brain Res 738:53–59PubMedCrossRef Di Monte DA, DeLanney LE, Irwin I, Royland JE, Chan P, Jakowec MW, Langston JW (1996) Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys. Brain Res 738:53–59PubMedCrossRef
go back to reference Dixon Clarke SE, Ramsay RR (2011) Dietary inhibitors of monoamine oxidase A. J Neural Transm 118:1031–1041PubMedCrossRef Dixon Clarke SE, Ramsay RR (2011) Dietary inhibitors of monoamine oxidase A. J Neural Transm 118:1031–1041PubMedCrossRef
go back to reference Erdem SS, Karahan O, Yildiz I, Yelekci K (2006) A computational study on the amine-oxidation mechanism of monoamine oxidase: insight into the polar nucleophilic mechanism. Org Biomol Chem 4:646–658PubMedCrossRef Erdem SS, Karahan O, Yildiz I, Yelekci K (2006) A computational study on the amine-oxidation mechanism of monoamine oxidase: insight into the polar nucleophilic mechanism. Org Biomol Chem 4:646–658PubMedCrossRef
go back to reference Ertem MZ, Cramer CJ, Himo F, Siegbahn PEM (2012) N-O bond cleavage mechanism(s) in nitrous oxide reductase. J Biol Inorg Chem 17:687–698PubMedCrossRef Ertem MZ, Cramer CJ, Himo F, Siegbahn PEM (2012) N-O bond cleavage mechanism(s) in nitrous oxide reductase. J Biol Inorg Chem 17:687–698PubMedCrossRef
go back to reference Foster JP, Weinhold F (1980) Natural hybrid orbitals. J Am Chem Soc 102:7211–7218CrossRef Foster JP, Weinhold F (1980) Natural hybrid orbitals. J Am Chem Soc 102:7211–7218CrossRef
go back to reference Fowler CJ, Mantle TJ, Tipton KF (1982) The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline. Biochem Pharmacol 31:3555–3561PubMedCrossRef Fowler CJ, Mantle TJ, Tipton KF (1982) The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline. Biochem Pharmacol 31:3555–3561PubMedCrossRef
go back to reference Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JA Jr, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas Ö, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ (2009) Gaussian 09, revision A.1, Gaussian Inc, Wallingford Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JA Jr, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas Ö, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ (2009) Gaussian 09, revision A.1, Gaussian Inc, Wallingford
go back to reference Gärtner B, Hemmerich P, Zeller EA (1976) Structure of flavin adducts with acetylenic substrates. Chemistry of monoamine oxidase and lactate oxidase inhibition. Eur J Biochem 63:211–221PubMedCrossRef Gärtner B, Hemmerich P, Zeller EA (1976) Structure of flavin adducts with acetylenic substrates. Chemistry of monoamine oxidase and lactate oxidase inhibition. Eur J Biochem 63:211–221PubMedCrossRef
go back to reference Georgieva P, Himo F (2010) Quantum chemical modeling of enzymatic reactions: the case of histone lysine methyltransferase. J Comput Chem 31:1707–1714 (and references cited therein) Georgieva P, Himo F (2010) Quantum chemical modeling of enzymatic reactions: the case of histone lysine methyltransferase. J Comput Chem 31:1707–1714 (and references cited therein)
go back to reference Goodman LS, Brunton LL, Chabner B, Knollmann BC (2011) Goodman & Gilman’s pharmacological basis of therapeutics, 12th edn. McGraw-Hill, New York Goodman LS, Brunton LL, Chabner B, Knollmann BC (2011) Goodman & Gilman’s pharmacological basis of therapeutics, 12th edn. McGraw-Hill, New York
go back to reference Hardman JG, Limbird LE, Gilman AG (2005) Goodman & Gilman’s the pharmacological basis of therapeutics, 11th edn. McGraw-Hill, New York Hardman JG, Limbird LE, Gilman AG (2005) Goodman & Gilman’s the pharmacological basis of therapeutics, 11th edn. McGraw-Hill, New York
go back to reference Himo F, Siegbahn PEM (2003) Quantum chemical studies of radical-containing enzymes. Chem Rev 103:2421–2456PubMedCrossRef Himo F, Siegbahn PEM (2003) Quantum chemical studies of radical-containing enzymes. Chem Rev 103:2421–2456PubMedCrossRef
go back to reference Hubálek F, Binda C, Li M, Herzig Y, Sterling J, Youdim MB, Mattevi A, Edmondson DE (2004) Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues. J Med Chem 47:1760–1766PubMedCrossRef Hubálek F, Binda C, Li M, Herzig Y, Sterling J, Youdim MB, Mattevi A, Edmondson DE (2004) Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues. J Med Chem 47:1760–1766PubMedCrossRef
go back to reference Inaba-Hasegawa K, Akao Y, Maruyama W, Naoi M (2012) Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase. J Neural Transm 119:405–414PubMedCrossRef Inaba-Hasegawa K, Akao Y, Maruyama W, Naoi M (2012) Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase. J Neural Transm 119:405–414PubMedCrossRef
go back to reference Inaba-Hasegawa K, Akao Y, Maruyama W, Naoi M (2013) Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells. J Neural Transm 120:435–444PubMedCrossRef Inaba-Hasegawa K, Akao Y, Maruyama W, Naoi M (2013) Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells. J Neural Transm 120:435–444PubMedCrossRef
go back to reference Kamerlin SCL, Warshel A (2010) The EVB as a quantitative tool for formulating simulations and analyzing biological and chemical reactions. Faraday Discuss 145:71–106CrossRef Kamerlin SCL, Warshel A (2010) The EVB as a quantitative tool for formulating simulations and analyzing biological and chemical reactions. Faraday Discuss 145:71–106CrossRef
go back to reference Kamerlin SCL, Warshel A (2011a) The empirical valence bond model: theory and applications. WIREs Comput Mol Sci 1:30–45CrossRef Kamerlin SCL, Warshel A (2011a) The empirical valence bond model: theory and applications. WIREs Comput Mol Sci 1:30–45CrossRef
go back to reference Kamerlin SCL, Warshel A (2011b) Multiscale modeling of biological functions. PhysChemChemPhys 13:10401–10411 Kamerlin SCL, Warshel A (2011b) Multiscale modeling of biological functions. PhysChemChemPhys 13:10401–10411
go back to reference Li M, Binda C, Mattevi A, Edmondson DE (2006) Functional role of the “aromatic cage” in human monoamine oxidase B: structures and catalytic properties of Tyr435 mutant proteins. Biochemistry 45:4775–4784PubMedCrossRef Li M, Binda C, Mattevi A, Edmondson DE (2006) Functional role of the “aromatic cage” in human monoamine oxidase B: structures and catalytic properties of Tyr435 mutant proteins. Biochemistry 45:4775–4784PubMedCrossRef
go back to reference Lu X, Ji H, Silverman RB (2002) in Flavins and flavoproteins. In: Chapman S, Perham R, Scrutton NS (eds), University Park Press, Baltimore, pp 817–830 Lu X, Ji H, Silverman RB (2002) in Flavins and flavoproteins. In: Chapman S, Perham R, Scrutton NS (eds), University Park Press, Baltimore, pp 817–830
go back to reference Maycock AL, Abeles RH, Salach JI, Singer TP (1976) The structure of the covalent adduct formed by the interaction of 3-dimethylamino-1-propyne and the flavine of mitochondrial amine oxidase. Biochemistry 15:114–125PubMedCrossRef Maycock AL, Abeles RH, Salach JI, Singer TP (1976) The structure of the covalent adduct formed by the interaction of 3-dimethylamino-1-propyne and the flavine of mitochondrial amine oxidase. Biochemistry 15:114–125PubMedCrossRef
go back to reference Menazza S, Blaauw B, Tiepolo T, Toniolo L, Braghetta P, Spolaore B, Reggiani C, Di Lisa F, Bonaldo P, Canton M (2010) Oxidative stress by monoamine oxidases is causally involved in myofiber damage in muscular dystrophy. Hum Mol Genet 19:4207–4215 Menazza S, Blaauw B, Tiepolo T, Toniolo L, Braghetta P, Spolaore B, Reggiani C, Di Lisa F, Bonaldo P, Canton M (2010) Oxidative stress by monoamine oxidases is causally involved in myofiber damage in muscular dystrophy. Hum Mol Genet 19:4207–4215
go back to reference Miller JR, Edmondson DE (1999) Structure-activity relationships in the oxidation of para-substituted benzylamine analogues by recombinant human liver monoamine oxidase A. Biochemistry 38:13670–13683 Miller JR, Edmondson DE (1999) Structure-activity relationships in the oxidation of para-substituted benzylamine analogues by recombinant human liver monoamine oxidase A. Biochemistry 38:13670–13683
go back to reference Patton GC, Stenmark P, Gollapalli DR, Sevastik R, Kursula P, Flodin S, Schuler H, Swales CT, Eklund H, Himo F, Nordlund P, Hedstrom L (2011) Cofactor mobility determines reaction outcome in the IMPDH and GMPR (β-α)8 barrel enzymes. Nat Chem Biol 7:950–958PubMedCrossRef Patton GC, Stenmark P, Gollapalli DR, Sevastik R, Kursula P, Flodin S, Schuler H, Swales CT, Eklund H, Himo F, Nordlund P, Hedstrom L (2011) Cofactor mobility determines reaction outcome in the IMPDH and GMPR (β-α)8 barrel enzymes. Nat Chem Biol 7:950–958PubMedCrossRef
go back to reference Ramsay RR, Olivieri A, Holt A (2011) An improved approach to steady-state analysis of monoamine oxidases. J Neural Transm 118:1003–1019PubMedCrossRef Ramsay RR, Olivieri A, Holt A (2011) An improved approach to steady-state analysis of monoamine oxidases. J Neural Transm 118:1003–1019PubMedCrossRef
go back to reference Rang HP, Dale MM, Ritter JM, Flower RJ (2007) Rang & Dale’s Pharmacology, 6th edn. Churchill Livingstone, Philadelphia Rang HP, Dale MM, Ritter JM, Flower RJ (2007) Rang & Dale’s Pharmacology, 6th edn. Churchill Livingstone, Philadelphia
go back to reference Senda T, Senda M, Kimura S, Ishida T (2009) Redox control of protein conformation in flavoproteins. Antioxid Redox Sign 11:1741–1766CrossRef Senda T, Senda M, Kimura S, Ishida T (2009) Redox control of protein conformation in flavoproteins. Antioxid Redox Sign 11:1741–1766CrossRef
go back to reference Shih JC, Chen K, Ridd M (1999) Monoamine oxidase: from genes to behavior. J Annu Rev Neurosci 22:197–217CrossRef Shih JC, Chen K, Ridd M (1999) Monoamine oxidase: from genes to behavior. J Annu Rev Neurosci 22:197–217CrossRef
go back to reference Siegbahn PEM, Himo F (2011) The quantum chemical cluster approach for modeling enzyme reactions. WIREs Comput Mol Sci 1:323–336CrossRef Siegbahn PEM, Himo F (2011) The quantum chemical cluster approach for modeling enzyme reactions. WIREs Comput Mol Sci 1:323–336CrossRef
go back to reference Silverman RB (1995) Radical ideas about monoamine oxidase. Acc Chem Res 28:335–342CrossRef Silverman RB (1995) Radical ideas about monoamine oxidase. Acc Chem Res 28:335–342CrossRef
go back to reference Son S-Y, Ma J, Kondou Y, Yoshimura M, Yamashita E, Tsukihara T (2008) Structure of human monoamine oxidase A at 2.2 Å resolution: the control of opening the entry for substrates/inhibitors. Proc Natl Acad Sci USA 105:5739–5744PubMedCrossRef Son S-Y, Ma J, Kondou Y, Yoshimura M, Yamashita E, Tsukihara T (2008) Structure of human monoamine oxidase A at 2.2 Å resolution: the control of opening the entry for substrates/inhibitors. Proc Natl Acad Sci USA 105:5739–5744PubMedCrossRef
go back to reference Szewczuk LM, Culhane JC, Yang M, Majumdar A, Yu H, Cole PA (2007) Mechanistic analysis of a suicide inactivator of histone demethylase LSD1. Biochemistry 46:6892–6902PubMedCrossRef Szewczuk LM, Culhane JC, Yang M, Majumdar A, Yu H, Cole PA (2007) Mechanistic analysis of a suicide inactivator of histone demethylase LSD1. Biochemistry 46:6892–6902PubMedCrossRef
go back to reference Trouche E, Mias C, Seguelas MH, Ordener C, Cussac D, Parini A (2010) Characterization of monoamine oxidases in mesenchymal stem cells: role in hydrogen peroxide generation and serotonin-dependent apoptosis. Stem Cells Dev 19:1571–1578PubMedCrossRef Trouche E, Mias C, Seguelas MH, Ordener C, Cussac D, Parini A (2010) Characterization of monoamine oxidases in mesenchymal stem cells: role in hydrogen peroxide generation and serotonin-dependent apoptosis. Stem Cells Dev 19:1571–1578PubMedCrossRef
go back to reference Vianello R, Repič M, Mavri J (2012) How are biogenic amines metabolized by monoamine oxidases? Eur J Org Chem 36:7057–7065CrossRef Vianello R, Repič M, Mavri J (2012) How are biogenic amines metabolized by monoamine oxidases? Eur J Org Chem 36:7057–7065CrossRef
go back to reference Walsh JD, Miller AF (2003) Flavin reduction potential tuning by substitution and bending. J Mol Struct: Theochem 623:185–195CrossRef Walsh JD, Miller AF (2003) Flavin reduction potential tuning by substitution and bending. J Mol Struct: Theochem 623:185–195CrossRef
go back to reference Youdim MBH, Bakhle YS (2006) Monoamine oxidase: isoforms and inhibitors in Parkinson’s disease and depressive illness. Br J Pharmacol 147:S287–S296PubMedCrossRef Youdim MBH, Bakhle YS (2006) Monoamine oxidase: isoforms and inhibitors in Parkinson’s disease and depressive illness. Br J Pharmacol 147:S287–S296PubMedCrossRef
go back to reference Youdim MBH, Collins GGS, Sandler M, Bevan-Jones AB, Pare CM, Nicholson WJ (1972) Human brain monoamine oxidase: multiple forms and selective inhibitors. Nature 236:225–228PubMedCrossRef Youdim MBH, Collins GGS, Sandler M, Bevan-Jones AB, Pare CM, Nicholson WJ (1972) Human brain monoamine oxidase: multiple forms and selective inhibitors. Nature 236:225–228PubMedCrossRef
go back to reference Youdim MBH, Edmondson D, Tipton KF (2006) The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 7:295–309PubMedCrossRef Youdim MBH, Edmondson D, Tipton KF (2006) The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 7:295–309PubMedCrossRef
go back to reference Zheng YJ, Ornstein RL (1996) A theoretical study of the structures of flavin in different oxidation and protonation states. J Am Chem Soc 118:9402–9408CrossRef Zheng YJ, Ornstein RL (1996) A theoretical study of the structures of flavin in different oxidation and protonation states. J Am Chem Soc 118:9402–9408CrossRef
Metadata
Title
Quantum-chemical approach to determining the high potency of clorgyline as an irreversible acetylenic monoamine oxidase inhibitor
Authors
Matic Pavlin
Janez Mavri
Matej Repič
Robert Vianello
Publication date
01-06-2013
Publisher
Springer Vienna
Published in
Journal of Neural Transmission / Issue 6/2013
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-013-1016-y

Other articles of this Issue 6/2013

Journal of Neural Transmission 6/2013 Go to the issue

Neurology and Preclinical Neurological Studies - Review Article

The impairment of lysyl oxidase in keratoconus and in keratoconus-associated disorders